Sec Form 13G Filing - Stonepine Capital Management, LLC filing for CalciMedica, Inc. (CALC) - 2024-12-13

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage calculated based on (a) 480,400 shares of Common Stock beneficially owned by the reporting person, plus 261,301 shares of Common Stock underlying warrants beneficially owned by the reporting person, and (b) 13,481,917 shares of Common Stock outstanding on November 6, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024.


SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage calculated based on (a) 480,400 shares of Common Stock beneficially owned by the reporting person, plus 261,301 shares of Common Stock underlying warrants beneficially owned by the reporting person, and (b) 13,481,917 shares of Common Stock outstanding on November 6, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024.


SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage calculated based on (a) 480,400 shares of Common Stock beneficially owned by the reporting person, plus 261,301 shares of Common Stock underlying warrants beneficially owned by the reporting person, and (b) 13,481,917 shares of Common Stock outstanding on November 6, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024.


SCHEDULE 13G



Comment for Type of Reporting Person:  Percentage calculated based on (a) 480,400 shares of Common Stock beneficially owned by the reporting person, plus 261,301 shares of Common Stock underlying warrants beneficially owned by the reporting person, and (b) 13,481,917 shares of Common Stock outstanding on November 6, 2024, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2024.


SCHEDULE 13G
< /tr>

 
Stonepine Capital Management, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:12/12/2024
 
Stonepine Capital, L.P.
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member of the General Partner, Stonepine, GP LLC
Date:12/12/2024
 
Stonepine GP, LLC
 
Signature:/s/ Jon M. Plexico
Name/Title:Managing Member
Date:12/12/2024
 
Jon M. Plexico
 
Signature:/s/ Jon M. Plexico
Name/Title:Reporting person
Date:12/12/2024
Exhibit Information

Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

primary_doc.xml